Alistair S. McLaren

Signature Gene Expression Profiles Discriminate between Isoniazid-, Thiolactomycin-, and Triclosan-Treated <i>Mycobacterium tuberculosis</i>

Joanna Betts, Alistair S. McLaren, Mark Lennon et al. · Antimicrobial Agents and Chemotherapy · 2003 · 143 citations · Full text

Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy

Agatha Schlüter, Lluı́s Espinosa, Stéphane Fourcade et al. · Human Molecular Genetics · 2011 · 71 citations · Full text

Ranitidine bismuth citrate: a novel anti‐ulcer agent with different physico‐chemical characteristics and improved biological activity to a bismuth citrate‐ranitidine admixture.

A. A. McColm, Alistair S. McLaren, G. KLINKERT et al. · Alimentary Pharmacology & Therapeutics · 1996 · 65 citations

Gastric anti‐secretory, mucosal protective, anti‐pepsin and anti‐Helicobacter properties of ranitidine bismuth citrate

R. Stables, Callum J. Campbell, Nick M. Clayton et al. · Alimentary Pharmacology & Therapeutics · 1993 · 58 citations

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +14

Characterization of the low-pH responses of Helicobacter pylori using genomic DNA arrays

Elaine Allan, Christopher L. Clayton, Alistair S. McLaren et al. · Microbiology · 2001 · 55 citations